19 insiders reported 223 Form 4 transactions for NEUROCRINE BIOSCIENCES INC (NBIX) over the past 18 months (most recent 2026-09-15). Recent activity: GORMAN KEVIN CHARLES (Director) Buy 14,343 shares, Gano Kyle (Chief Executive Officer) Sell 994 shares, Gano Kyle (Chief Executive Officer) Buy 6,275 shares, BENEVICH ERIC (Chief Commercial Officer) Buy 6,275 shares, ABERNETHY MATT (Chief Financial Officer) Buy 5,020 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | GORMAN KEVIN CHARLES | Director | Buy | 14,343 | $0 |
| 2026-09-15 | Gano Kyle | Chief Executive Officer | Sell | 994 | $155,283 |
| 2026-09-15 | Gano Kyle | Chief Executive Officer | Buy | 6,275 | $0 |
| 2026-09-15 | BENEVICH ERIC | Chief Commercial Officer | Buy | 6,275 | $0 |
| 2026-09-15 | ABERNETHY MATT | Chief Financial Officer | Buy | 5,020 | $0 |
| 2026-09-15 | Cooke Julie | Chief Human Resources Officer | Buy | 3,587 | $0 |
| 2026-09-15 | Keswani Sanjay Chandru | Chief Medical Officer | Buy | 3,914 | $0 |
| 2026-09-15 | Lippoldt Darin | Chief Legal Officer | Buy | 4,483 | $0 |
| 2026-09-15 | Boyer David W. | Chief Corp. Affairs Officer | Buy | 3,587 | $0 |
| 2026-09-15 | Delaet Ingrid | Chief Regulatory Officer | Buy | 4,483 | $0 |
| 2026-09-15 | GORMAN KEVIN CHARLES | Director | Sell | 7,839 | $1.2M |
| 2026-09-15 | Lippoldt Darin | Chief Legal Officer | Sell | 2,419 | $377,896 |
| 2026-09-15 | Gano Kyle | Chief Executive Officer | Sell | 3,386 | $528,961 |
| 2026-09-15 | BENEVICH ERIC | Chief Commercial Officer | Sell | 3,386 | $528,961 |
| 2026-09-15 | ABERNETHY MATT | Chief Financial Officer | Sell | 2,709 | $423,200 |
| 2026-09-15 | Cooke Julie | Chief Human Resources Officer | Sell | 1,936 | $302,442 |
| 2026-09-15 | Keswani Sanjay Chandru | Chief Medical Officer | Sell | 2,112 | $329,937 |
| 2026-09-15 | Onyia Jude | Chief Scientific Officer | Sell | 1,936 | $302,442 |
| 2026-09-15 | Boyer David W. | Chief Corp. Affairs Officer | Sell | 1,936 | $302,442 |
| 2026-09-15 | Delaet Ingrid | Chief Regulatory Officer | Sell | 2,419 | $377,896 |
| 2026-09-15 | Gano Kyle | Chief Executive Officer | Buy | 1,842 | $0 |
| 2026-09-15 | ABERNETHY MATT | Chief Financial Officer | Sell | 2,311 | $363,285 |
| 2026-09-15 | Boyer David W. | Chief Corp. Affairs Officer | Sell | 826 | $130,051 |
| 2026-09-15 | Onyia Jude | Chief Scientific Officer | Buy | 3,587 | $0 |
| 2026-09-10 | BENEVICH ERIC | Chief Commercial Officer | Buy | 3,194 | $138,109 |
Source: SEC Form 4 filings · as of 2026-09-15